OSTEOARTHROSIS: NEW POSSIBILITIES FOR DELAYED-ACTING SYMPTOM-MODIFYING THERAPY

Show other versions (1)

Objective: to study the efficacy, tolerability, and safety of Artradol in patients with knee osteoarthrosis.Subjects and methods. The investigation enrolled 35 patients of both sexes, mean age 63,45 ± 6,9 years, with stages II and III gonarthrosisand walking pain intensity > 40 mm visual anal...

Full description

Bibliographic Details
Published in:Klinicist
Main Authors: N. A. Shostak, N. G. Pravdyuk, A. A. Klimenko, A. A. Kondrashov, V. S. Shemenkova, V. A. Egorova
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Subjects:
osteoarthrosis
gonarthrosis
delayed-acting symptom-modifying effect
chondroitin sulfate
artradol
Online Access:https://klinitsist.abvpress.ru/Klin/article/view/18

Internet

https://klinitsist.abvpress.ru/Klin/article/view/18

Similar Items